154 related articles for article (PubMed ID: 21511399)
1. Acute phase protein response in experimental canine leishmaniasis.
Martinez-Subiela S; Strauss-Ayali D; Cerón JJ; Baneth G
Vet Parasitol; 2011 Aug; 180(3-4):197-202. PubMed ID: 21511399
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil.
Andrade HM; Toledo VP; Pinheiro MB; Guimarães TM; Oliveira NC; Castro JA; Silva RN; Amorim AC; Brandão RM; Yoko M; Silva AS; Dumont K; Ribeiro ML; Bartchewsky W; Monte SJ
Vet Parasitol; 2011 Sep; 181(2-4):83-90. PubMed ID: 21641721
[TBL] [Abstract][Full Text] [Related]
3. Splenic immune responses during canine visceral leishmaniasis.
Strauss-Ayali D; Baneth G; Jaffe CL
Vet Res; 2007; 38(4):547-64. PubMed ID: 17540157
[TBL] [Abstract][Full Text] [Related]
4. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
5. Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.
Daza González MA; Fragío Arnold C; Fermín Rodríguez M; Checa R; Montoya A; Portero Fuentes M; Rupérez Noguer C; Martínez Subiela S; Cerón JJ; Miró G
Vet J; 2019 Mar; 245():22-28. PubMed ID: 30819422
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
7. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
8. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
Gravino AE
Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
[TBL] [Abstract][Full Text] [Related]
9. Polyarthritis associated with visceral leishmaniasis in a juvenile dog.
Santos M; Marcos R; Assunção M; Matos AJ
Vet Parasitol; 2006 Nov; 141(3-4):340-4. PubMed ID: 16824686
[TBL] [Abstract][Full Text] [Related]
10. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
11. Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in the endemic areas.
Saridomichelakis MN; Mylonakis ME; Leontides LS; Billinis C; Koutinas AF; Galatos AD; Gouletsou P; Diakou A; Kontos VI
Vet Parasitol; 2005 Jun; 130(3-4):199-205. PubMed ID: 15905034
[TBL] [Abstract][Full Text] [Related]
12. Acute-phase proteins in dogs naturally infected with Leishmania infantum during and after long-term therapy with allopurinol.
Sasanelli M; Paradies P; de Caprariis D; Greco B; De Palo P; Palmisano D; Carelli G
Vet Res Commun; 2007 Aug; 31 Suppl 1():335-8. PubMed ID: 17682908
[No Abstract] [Full Text] [Related]
13. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
Daneshvar H; Molaei MM; Kamiabi H; Burchmore R; Hagan P; Stephen Phillips R
Parasite Immunol; 2010; 32(11-12):722-30. PubMed ID: 21039612
[TBL] [Abstract][Full Text] [Related]
15. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin and paraoxonase-1 in canine leishmaniosis.
Martinez-Subiela S; Cerón JJ; Strauss-Ayali D; Garcia-Martinez JD; Tecles F; Tvarijonaviciute A; Caldin M; Baneth G
Comp Immunol Microbiol Infect Dis; 2014 Jan; 37(1):23-9. PubMed ID: 24268430
[TBL] [Abstract][Full Text] [Related]
17. A long term experimental study of canine visceral leishmaniasis.
Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
Int J Parasitol; 2007 May; 37(6):683-93. PubMed ID: 17239885
[TBL] [Abstract][Full Text] [Related]
18. Clinical follow-up examination after treatment of canine leishmaniasis.
Moritz A; Steuber S; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
Martínez-Subiela S; Bernal LJ; Cerón JJ
Am J Vet Res; 2003 Aug; 64(8):1021-6. PubMed ID: 12926596
[TBL] [Abstract][Full Text] [Related]
20. Evidence of an acute phase response in dogs naturally infected with Babesia canis.
Matijatko V; Mrljak V; Kis I; Kucer N; Forsek J; Zivicnjak T; Romić Z; Simec Z; Ceron JJ
Vet Parasitol; 2007 Mar; 144(3-4):242-50. PubMed ID: 17116368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]